Annovis Bio Inc ANVS shares are trading lower by 17.9% to $6.69 Tuesday morning after the company announced a public offering of 1.25 million units, each consisting of one common stock share and one warrant to purchase an additional common stock share.
The combined price for each unit is $6.00, with an expected gross proceeds of approximately $7.5 million, subject to deductions for expenses.
The offering is set to close around November 2, with Canaccord Genuity serving as the primary bookrunner.
See Also: Pfizer Q3 Earnings
According to data from Benzinga Pro, ANVS has a 52-week high of $23.89 and a 52-week low of $7.40.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
